THE World Health Organisation approved today Indian vaccine against coronavirus Covovax, the WHO said in a statement.
This vaccine “is manufactured by the Serum Institute of India under license Novavax and is part of its portfolio Covax “(of the international vaccine distribution system against Covid), which will allow to strengthen the efforts made in order to vaccinate more people in low-income countries”, the international organization underlined, according to the RES EIA.
“Vaccines remain one of the most effective methods of protection against severe forms and deaths caused by SARS-COV-2, despite the emergence of new variants“, Noted Dr. Mariangela Simaou, responsible for WHO access to medicines.
The approval “is expected to facilitate access to vaccines for poor countries, 41 of which are still unable to vaccinate 10% of their population, while 98% of countries have not yet reached 40%,” he added. .
It is pointed out that the WHO has set a goal of vaccination 40% of the population all countries by the end of the year.
The Covovax vaccine requires two doses and can be stored at temperatures of 2 to 8 degrees, such as in commercial refrigerators.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
